Peripheral Nerve Injuries Clinical Trial
Official title:
Evaluation of the Diagnostic Threshold of SSEP of Brachial Plexus Injury
Brachial plexus block is a common regional anesthesia technique which is performed by anesthesiologists to anesthetize the arm for surgery. In this study, we are investigating the relationship between the nerve conduction (induced by brachial plexus block) and the patients' symptoms before and after the brachial plexus block. We will attach a nerve conduction device (SSEP device) to monitor the patients' arm conduction and we will assess the patients' symptoms simultaneously.
Perioperative peripheral nerve injury (PNI) is an under-recognized and under-investigated
complication of general anesthesia and continues to impact postoperative recovery resulting
in patient disability malpractice claims.(1-5) In the American Society of Anesthesiologists
(ASA) Closed Claims Analysis (published in 1999), PNI was the second most common cause of
claims other than death. (6-7) This claim pattern has remained essentially unchanged over the
past 3 decades and the average settlement was $123,000 US Dollar/claim (unpublished data from
ASA closed claims analysis). The overall incidence of PNI varies across different surgical
procedures, and it is significantly affected by the underlying patient comorbidities and
pre-existing peripheral neuropathy. Despite considerable implications of PNI to both the
patients and clinicians, little progress has been made in the past three decades in
developing a reliable intraoperative monitoring technique for its early detection and
prevention. SSEP monitoring has long been used in neurology as a means to diagnose peripheral
neuropathy and has been used for the early detection of intraoperative PNI caused by improper
patient positioning. A few retrospective studies have found that reversal of intraoperative
SSEP signal changes (e.g. correct the patient's arm position in the event of a positioning
related peripheral nerve compromise) prevented postoperative neuropathy, suggesting SSEP
could be used to detect intraoperative PNI and that prompt intervention could reverse
neurological injury (8-10). However, to date, there has not been a study that clearly defines
how the magnitudes of SSEP changes relate to the severity of peripheral nerve dysfunction.
Due to this lack of information, the current thresholds that are used for diagnosing PNI in a
variety of surgical procedures are largely based on the results of SSEP monitoring in spinal
cord injury. The traditional diagnostic criteria (used in spinal cord injury) might not be
applicable for PNI. Fundamentally, there is also a lack of a clinical study that defines
significant and non-significant changes for PNI. Most current available evidence regarding
SSEP in PNI is retrospective and mainly derived from patients being monitored for spinal cord
or cerebral injury during neurosurgical procedures. The lack of well-validated diagnostic
criteria is one of the key issues in preventing the use of SSEP for monitoring peripheral
nerves during surgery. As such, further studies are required to characterize the relationship
between SSEP changes and peripheral nerve dysfunction and re-define the threshold (or cut-off
values) for significant SSEP change for PNI.
This is a prospective cohort study to evaluate the relationship between the peripheral nerve
dysfunction, and SSEP signal changes in patients who will receive a brachial plexus block for
their surgical procedure. Brachial plexus block is a regional anesthesia technique routinely
performed by anesthesiologists where the nerves in the arm are blocked with local anesthetics
to prohibit movement and sensation. In LHSC, the average brachial plexus block performed is
around 10-15 patients/day for various upper limb surgeries. In this study, the patients with
brachial plexus block will be used as a model of brachial plexus injury to assess the
relationship between intraoperative brachial plexus injury and the SSEP changes. Brachial
plexus block in awake patients is an attractive model to study brachial plexus injury,
because it provides transient and progressive de-afferentation state of brachial plexus
dysfunction (mimicking brachial plexus injury), allows for real-time assessment of the
relationship between clinical symptoms and SSEP changes (awake patients), and overcomes
obvious practical limitations of investigating intraoperative PNI (small sample size of
patients with intraoperative brachial plexus injury). In this study, 50 consecutive patients
who required a brachial plexus block for their surgery, will be recruited. This study will be
performed in the "Block Room" of either London Health Science Centre or St Joesph Hospital,
London, Ontario. After obtaining informed consent, an independent assessor (hand specialist)
will perform a baseline assessment of the sensory and motor function of the upper limb. The
sensory function will be quantified by a two-point discrimination test in each dermatome. The
motor function will be quantified by the motor score in each myotome. The patients will be
attached to the automated SSEP monitor to obtain baseline upper limb SSEP signals. Median,
ulnar and radial nerves will be monitored. After satisfactory baseline SSEP recordings have
been obtained, a brachial plexus block will be performed in the usual fashion to achieve
complete sensory and motor blockage (approx. 30 min). This provides a unique experimental
condition to assess the relationship between the brachial plexus dysfunction and the SSEP
signal changes. An independent assessor (hand specialist) will re-assess the patients'
sensory and motor function every 5 minutes (up to 30 minutes during the onset of the block).
SSEP recording will be concomitantly obtained. A total of 300 data pairs (6 data pairs for
each patient) will be obtained for analysis. In this study, the Evoked Potential Assessment
Device (EPAD®, SafeOp Surgical, Hunt Valley, MD) SSEP machine will be used. It is a novel,
simplified, automated SSEP monitoring device (FDA approved), designed to detect
intraoperative PNI. The key features of EPAD® are that only the surface adhesive electrodes
(i.e. no subdermal needle electrodes) will be used, as well as there is newly artifact
rejection and optimization algorithm that permit SSEP recording in awake patients.
Prior to performing the brachial plexus block in the "Block room", a complete neurological
examination will be performed including motor score and 2-point discrimination test. Eligible
patients will be recruited after obtained informed consent. The baseline SSEP of the
participants will be recorded using the EPAD@ device. After the participants received the
brachial plexus block (as part of their standard of care), the participants will be
monitoring the progressive changes of SSEP signals while the effect of brachial plexus block
gradually onset (usually takes around 30 minutes). An independent assessor (hand specialist
blinded to the SSEP results) will concomitantly re-assess the patients' sensory and motor
function every 5 minutes (up to 30 minutes during the onset of the block).
The primary analysis will be on describing the relationship between the severity of the
neurological deficits (impaired sensory and/or motor function) and SSEP changes (amplitude
and/or latency changes). Secondarily, an optimal cut-off limit using Youden index and/or
logistic regression-derived likelihood ratio functions will be determined. A
Receiver-operating-curve for the new cut-off limits will be assessed. REDCapTM will be used
for electronic data collection and STATA (version 14) will be used for statistical analysis
in all the studies. These new cut-off limits in comparison with conventional criteria in our
subsequent clinical studies will be compared.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04572906 -
Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries
|
Phase 2 | |
Active, not recruiting |
NCT03999424 -
Autologous Human Schwann Cells in Peripheral Nerve Repair
|
Phase 1 | |
Not yet recruiting |
NCT05848778 -
Non-invasive Therapy to Drive Nerve Regeneration
|
N/A | |
Completed |
NCT02070367 -
Somatosensory Assessment and Rehabilitation of Allodynia (SARA)
|
N/A | |
Recruiting |
NCT03205124 -
The Effect of Pre-operative Electrical Stimulation on Peripheral Nerve Regeneration.
|
Phase 2/Phase 3 | |
Recruiting |
NCT01526681 -
Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction
|
||
Recruiting |
NCT03422107 -
Somatosensory Evoked Potential (SSEP) Monitoring for Detection of Intraoperative Positional Neuropraxia
|
N/A | |
Active, not recruiting |
NCT05339594 -
REINVENT Registry (Registry of the Nerve Gap Repair From Integra)
|
||
Completed |
NCT02437695 -
Robot Assisted Radical Prostatecomy and Positional Injury
|
N/A | |
Completed |
NCT02786888 -
Prospective Comparison of Adductor Canal Block Performed With a Multiport Versus Single Bevel Needle
|
N/A | |
Completed |
NCT01954199 -
The Effectiveness of Neurodynamic Techniques in Patients With Nerve-Related Leg Pain
|
N/A | |
Withdrawn |
NCT02095899 -
Effect of Rufinamide on Chronic Postthoracotomy Pain Syndrome
|
Phase 2 | |
Recruiting |
NCT02403661 -
Electrical Stimulation to Enhance Peripheral Nerve Regeneration
|
N/A | |
Completed |
NCT03191032 -
Early Sensory Re-education of the Hand With a Sensor Glove Model
|
N/A | |
Recruiting |
NCT06209801 -
Mirror Therapy Integrated With Electrical Stimulation for Cortical Modulations
|
N/A | |
Recruiting |
NCT03913689 -
StimRouter Registry Clinical Protocol
|
||
Terminated |
NCT02459015 -
Performance Study of an Artificial Nerve Guide (Reaxon® Nerve Guide) to Treat Digital Nerve Lesions
|
N/A | |
Recruiting |
NCT03780855 -
Preliminary Evaluation of the Clinical Safety and Effectiveness of the Bionic Nerve Scaffold
|
N/A | |
Recruiting |
NCT05884125 -
Promoting Healing of Injured Nerves With Electrical Stimulation Therapy
|
N/A | |
Recruiting |
NCT04789044 -
Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion)
|
Phase 2 |